Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service
A high proportion of patients received adjuvant treatment, with a centralised clinic model leading to increased rates of adjuvant chemotherapy delivery. Completion of the full chemotherapy course was more critical than dose intensity. Larger prospective studies are needed to investigate the factors contributing to regional variations.
Authors
- Philip Whelan (ORCID: https://orcid.org/0000-0001-5770-2888)
- Olusola Olusesan Faluyi (ORCID: https://orcid.org/0000-0001-6710-2210)
- Timothy Gilbert (ORCID: https://orcid.org/0000-0003-4821-1897)
- Martyn Stott (ORCID: https://orcid.org/0000-0002-3536-8281)
- Marie McKay
- Richard Jackson
- John P. Neoptolemos
- Helen Wong
- Jessica Hale
- Paula Ghaneh
- Declan Dunne
- Daniel Palmer
- Christopher Halloran
Institutions
- University of Liverpool (GB)
- Heidelberg University (DE)
- Aintree University Hospitals NHS Foundation Trust (GB)
- University Hospital Heidelberg (DE)
- Clatterbridge Cancer Centre NHS Foundation Trust (GB)
Publication Details
- Journal
- British Journal of Cancer
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1038/s41416-026-03341-0
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00